
There is no single testosterone number that defines health for every adult man. A commonly cited standardized total testosterone reference interval is 264-916 ng/dL in healthy nonobese men aged 19-39. The AUA uses below 300 ng/dL as a reasonable diagnostic cutoff, alongside symptoms and two morning measurements. Laboratory method, SHBG, and free testosterone can change the interpretation.123
Key points
- The 264-916 ng/dL interval came from a specific healthy young reference population.1
- A diagnostic cutoff is not the same thing as a desired treatment level.23
- Borderline total results may need SHBG and an appropriate free testosterone assessment.3
What does a laboratory reference range mean?
A reference interval describes the distribution of results in a selected group tested by a particular method. It does not identify one ideal concentration for every person. A result near an endpoint deserves context, and a result outside an interval is not automatically a disease diagnosis.1 3
The widely cited 264-916 ng/dL interval comes from a harmonization study using four US and European cohorts. Investigators aligned measurements with a reference method and defined that interval in healthy nonobese men aged 19-39. The endpoints represented the 2.5th and 97.5th percentiles in that subgroup. The population selection is part of the finding, not a footnote that can be discarded.1
This also explains why the middle of a reference range is not a treatment prescription. A population distribution describes how values were spread; it does not show that moving each person to the median or upper endpoint improves health.
Why do clinicians also use 300 ng/dL?
The AUA identifies total testosterone below 300 ng/dL as a reasonable cutoff supporting a diagnosis of testosterone deficiency. The same guideline requires symptoms or signs and two early-morning measurements on separate occasions. The number is one element of a clinical definition, rather than a stand-alone pass or fail test.2
A value can therefore sit above one laboratory's lower reference limit and below a guideline cutoff. That is not necessarily a laboratory mistake. The two boundaries were constructed for different purposes: one describes a reference population, while the other supports clinical decisions.
Values around a boundary are also subject to biological and analytical variation. Treating a small difference as a sharp change in health overstates what a blood test can resolve. The more useful questions concern symptoms, reproducibility, collection conditions, and whether free testosterone is needed.3
A clinician can explain which threshold was used and why the assay and clinical findings support that choice. The explanation should remain understandable even when the laboratory flag and the guideline boundary do not match exactly.

How do reference intervals, cutoffs, and targets differ?
These concepts answer different questions. Confusing them can turn a laboratory report into an unsupported optimization plan. Reference intervals, diagnostic cutoffs, and treatment targets should be read according to their separate purposes.1 2 3
| Number type | Question it answers | What it cannot establish |
|---|---|---|
| Reference interval | Where did most results fall in a defined reference group? 1 | The ideal level for each individual |
| Diagnostic cutoff | At what level should a clinical diagnosis receive stronger consideration? 2 | A diagnosis without symptoms and repeat testing |
| Treatment target | What monitored range fits a diagnosed patient and a particular therapy? 3 | That an untreated healthy person should start therapy |
| Population average | What was typical in a study sample? 1 | The boundary between healthy and unhealthy |
Why do laboratories report different ranges?
Laboratories can use different assays, calibrations, reference populations, and reporting conventions. Standardization reduces disagreement, but the method still matters, especially near a clinical decision boundary. A result should be interpreted with the interval printed for that specific test.3 4
CDC's Hormone Standardization Program assesses whether participating methods meet analytical performance requirements. That is valuable information about measurement quality. It does not certify a diagnosis, guarantee that every specimen was collected correctly, or establish that a specific result explains someone's symptoms.4
When comparing results over time, keep the laboratory, units, and collection conditions as consistent as practical. A switch from one method to another may produce an apparent change that needs explanation. The blood test preparation guide covers timing and repeat collection, while the report itself should identify whether the measurement is total, free, or calculated.
How do ng/dL and nmol/L compare?
The same total testosterone concentration can be expressed in different units. To convert ng/dL to nmol/L, multiply by approximately 0.0347. Thus, 300 ng/dL is approximately 10.4 nmol/L. The conversion changes the notation, not the hormone concentration or the diagnostic certainty.3
Free testosterone is commonly reported in pg/mL, ng/dL, or pmol/L. Those figures cannot be compared directly with total testosterone numbers, and even free results in matching units may come from methods with different reference intervals. A total result of 300 and a free result of 10 are not two comparable scores.
Before interpreting a screenshot or an old report, identify the analyte, units, assay, reference interval, collection time, and treatment status. This basic check prevents a large share of apparent contradictions. Converting units is straightforward; converting one assay's clinical meaning into another's is not.
Can total testosterone look normal while free testosterone is low?
Yes. A higher SHBG concentration can maintain a total testosterone result within the reference interval while the unbound fraction is lower. Low SHBG can produce the opposite pattern: lower total testosterone with a relatively preserved free concentration. These are reasons to investigate a mismatch, not rules that make either number irrelevant.3 5
An analysis from the European Male Ageing Study associated low calculated free testosterone despite normal total testosterone with more androgen-related findings. It was observational, so it cannot demonstrate that prescribing testosterone to every person with that pattern improves symptoms.5
The total versus free testosterone comparison explains why the method matters. An equilibrium dialysis measurement or a validated calculation has a different evidence base from some direct analog assays. There is no universal free testosterone range that can be safely pasted onto every laboratory result.

Does a previous higher result define your personal normal?
An earlier result can provide context, particularly if it was measured with a comparable method and before a clear change in health. It does not establish a permanent personal target. Testosterone varies, and an isolated high value may have reflected the collection time, binding proteins, laboratory method, or ordinary biological variation.3 4
To compare an old and new report, first check whether both measured total testosterone and used the same units. Then check collection time, fasting status, health, medicines, and whether either result was obtained during hormone treatment. The comparison becomes weaker as these conditions diverge. A result from a different laboratory years earlier may still be worth discussing, but it is not a controlled before-and-after experiment.
A sustained change with new compatible symptoms is more informative than a small difference without symptoms. Even then, the next question is why the change occurred and whether current testing confirms deficiency. A prior concentration cannot tell you whether the testes, pituitary, binding proteins, or a new illness explains the difference.3
The practical distinction is between history and target. Historical results belong in the assessment because they can reveal a pattern. A treatment target requires a current diagnosis, a treatment-specific monitoring plan, and consideration of outcomes and adverse effects. One remembered number should not silently take over all three decisions.
What should happen after a borderline result?
A borderline result should lead to a structured review, rather than an immediate effort to raise the number. Confirm whether the sample was collected appropriately, whether symptoms fit, and whether repeat testing shows the same pattern. Acute illness, food intake, sleep disruption, medications, and binding proteins may be relevant.3
If biochemical deficiency is confirmed, LH and FSH help investigate why it is present. If results are consistently reassuring, ongoing symptoms still deserve attention through other plausible explanations. Repeating a broad hormone panel indefinitely without a clinical question can create confusion without improving care.
Age belongs in the history, but an age chart does not settle an individual diagnosis. The guide to testosterone levels by age examines why cross-sectional averages cannot predict a personal trajectory. The aim of evaluation is to identify a treatable condition and meaningful symptoms, not to win a percentile comparison.
Common questions
Is 299 ng/dL definitely abnormal while 301 is normal?
Should my testosterone be near the top of the laboratory range?
Can a normal total result rule out every hormone problem?
Can I compare an afternoon result with a morning result?
You can record both, but they were collected under different conditions. Diagnostic comparisons are more useful when samples follow the recommended morning collection process.3
References
- 1.Travison TG, et al. Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe. Journal of Clinical Endocrinology & Metabolism. 2017.
- 2.Mulhall JP, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. Journal of Urology. 2018; validity confirmed 2024.
- 3.Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. 2018.
- 4.Centers for Disease Control and Prevention. HoSt FAQs. Hormone Standardization Program.
- 5.Antonio L, et al. Low Free Testosterone Is Associated with Hypogonadal Signs and Symptoms in Men with Normal Total Testosterone. Journal of Clinical Endocrinology & Metabolism. 2016.
This article is for general education, not medical advice, diagnosis or a treatment recommendation. A licensed clinician can interpret the evidence in the context of your symptoms, tests, medicines and fertility plans.